SKI Market

Indian Indices

Nifty

26,205.30 320.50
(1.24%)

Sensex

85,609.51 1,022.50
( 1.21%)

Bank Nifty

59,528.05 707.75
( 1.20%)

Nifty IT

37,364.60 537.70
( 1.46%)

Global Indices

Nasdaq

47,129.48 660.20
(1.42%)

Dow Jones

6,786.30 60.18
(0.89%)

Hang Seng

49,532.43 872.91
(1.79%)

Nikkei 225

9,602.38 67.47
(0.71%)

Forex

USD-INR

89.21 -0.39
(-0.43%)

EUR-INR

102.81 -0.34
(-0.33%)

GBP-INR

116.86 -0.46
(-0.39%)

JPY-INR

0.57 0.00
(-0.65%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500124

INE089A01031

377.5672424

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DRREDDY

19.11

103155.01

EPS(TTM)

Face Value()

Div & Yield %

64.68

0.65

Back

BIL Vyapar reports consolidated net loss of Rs 0.81 crore in the September 2025 quarter

Nov 12,2025

Net Loss of BIL Vyapar reported to Rs 0.81 crore in the quarter ended September 2025 as against net loss of Rs 0.55 crore during the previous quarter ended September 2024. There were no Sales reported in the quarter ended September 2025 and during the previous quarter ended September 2024.

26,205.30 320.50 (1.24%)

85,609.51 1,022.50 ( 1.21%)

59,528.05 707.75 ( 1.20%)

37,364.60 537.70 ( 1.46%)

47,129.48 660.20 (1.42%)

6,786.30 60.18 (0.89%)

49,532.43 872.91 (1.79%)

9,602.38 67.47 (0.71%)

89.21 -0.39 (-0.43%)

102.81 -0.34 (-0.33%)

116.86 -0.46 (-0.39%)

0.57 0.00 (-0.65%)